ACOR Short Information, Acorda Therapeutics Inc.

Twenty Trading Day Totals
Total Shorted Volume	16,282,823
Total Actual Volume	75,878,743

Averages
Average Short Volume	814,141
Average Short Percentage	56.40%

Is there a ACOR Short Squeeze or Breakout about to happen?

See the ACOR Short Analysis for free Sign up or Login

Stock Date	Open Price	Close Price	High	Low	Total Volume	Short Volume	Short Percentage
2021-01-15	6.24	6.7	6.72	6.0765	1,457,458	209,745	51.7426
2021-01-14	6.1	6.37	6.66	5.776	2,273,573	457,667	59.2037
2021-01-13	7.16	6.15	7.18	5.5	36,186,069	7,364,210	59.7859
2021-01-12	4.11	4.24	4.27	4.1	312,145	80,736	58.4683
2021-01-11	4.03	4.1	4.18	3.98	247,289	61,148	52.1634
2021-01-08	4.18	4.11	4.18	3.99	327,315	32,732	37.1499
2021-01-07	3.96	4.16	4.28	3.93	322,864	87,952	64.8231
2021-01-06	4.07	3.905	4.28	3.89	434,133	109,538	61.2889
2021-01-05	3.82	4.04	4.18	3.67	577,765	127,712	61.2316
2021-01-04	3.57	3.8	3.83	3.37	868,528	169,976	55.2144
2020-12-31	0.7232	0.6901	0.82	0.6839	12,572,810	3,007,682	55.2605
2020-12-30	0.691	0.71	0.72	0.6757	2,118,242	451,103	57.1995
2020-12-29	0.72	0.6971	0.7299	0.6825	1,580,921	468,708	69.1015
2020-12-28	0.73	0.7071	0.74	0.7002	1,613,280	411,236	52.0987
2020-12-24	0.7515	0.724	0.76	0.71	1,446,487	243,414	56.8014
2020-12-23	0.7	0.7515	0.7796	0.7	3,586,729	924,555	57.8731
2020-12-22	0.7204	0.6954	0.73	0.6602	2,404,377	372,768	38.7506
2020-12-21	0.7	0.7204	0.75	0.69	3,115,959	388,968	39.4861
2020-12-18	0.7617	0.76	0.8	0.7551	2,213,749	808,662	76.9162
2020-12-17	0.745	0.7553	0.7885	0.7304	2,219,050	504,311	63.4611

Stock Information

Acorda Therapeutics Inc. Company Name:

ACOR Stock Symbol:

NASDAQ Market:

Acorda Therapeutics Inc. Website:

Get ACOR Alerts

News, Short Squeeze, Breakout and More Instantly...

ACOR - Acorda Therapeutics Announces Agreement for Sale of Manufacturing Operations and Long-Term Global Supply Agreement for INBRIJA®, Corporate Restructuring, and Enters into "At The Market" Offering Agreement

$80 million up-front payment will substantially increase cash balance Sale, restructuring and other operating expense reductions will reduce annual operating expenses by approximately $40 million Total 2021 non-GAAP operating expense guidance expected to be $130-$140 million ...
ACOR - Acorda Therapeutics to Present at 39th Annual J.P. Morgan Health Care Conference

Acorda Therapeutics, Inc. (NASDAQ: ACOR) announced that Ron Cohen, M.D., President and Chief Executive Officer, will present at the 39 th Annual J.P. Morgan Health Care Conference on Thursday, January 14, at 5:20 PM ET. A live audio webcast of the presentation can be accessed under ...
ACOR - Acorda Therapeutics to Present at H.C. Wainwright BIOCONNECT Virtual Conference

Acorda Therapeutics, Inc. (NASDAQ: ACOR) announced that Ron Cohen, M.D., President and Chief Executive Officer, will present during the January 11 th -14 th H.C. Wainwright BIOCONNECT Virtual Conference. An audio webcast of the presentation can be accessed under “Investor...